Locations
Los Angeles, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2016
Bionaut Labs is pioneering precision micro-technology to revolutionize the treatment of severe brain disorders. The company has developed microscale robots, known as Bionauts, which deliver biologics or small molecule therapies directly to targeted disease areas in the brain. This innovative approach allows for localized treatment and diagnostic detection, enhancing safety and efficacy. Bionaut Labs aims to overcome barriers in treating complex human anatomy, positioning itself as a leader in the neuro-oncology market with a focus on conditions like brainstem glioma and neurodegeneration. Their technology enables the application of advanced therapeutics, including gene therapy and CRISPR-Cas9, in challenging clinical settings, making it a compelling investment opportunity.
Something looks off?